Skip to main content
Reimbursement strategy

Cost-effective market access strategy for medical technologies in Europe

A holistic approach to reimbursement strategies trusted by global market leaders and SMEs

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Determinants of global cardiac implantable electrical device remote monitoring utilization - Results from an international survey

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Vandenberk et al. examined the global determinants of remote monitoring (RM) utilization in patients with cardiac implantable electronic devices through a survey of clinic personnel from 47 countries. The study revealed significant geographic variability in RM adoption, driven by economic factors, such as gross national income per capita and clinic funding models, along with differences between office-based and hospital-based settings. The authors emphasized the need for targeted efforts by all stakeholders to address disparities and enhance access to RM technologies worldwide.

Access the full-text article here.